Who is sponsoring NCT04404608?

NCT04404608 is sponsored by Dr Medhat Khafagy.

What drugs are being tested in NCT04404608?

Interventions in NCT04404608: Complete blood picture, bone marrow aspiration cytology.

What condition does NCT04404608 study?

NCT04404608 studies Lymphopenia.

Is NCT04404608 still recruiting?

NCT04404608 is currently completed. Last updated 20 July 2022.

Last reviewed 2022-07-20 · How we verify

NCT04404608

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Etiology of Lymphopenia in Covid19 Infection

Completed Last updated 20 July 2022

What this trial tests

trial testing Complete blood picture, bone marrow aspiration cytology in Lymphopenia in 172 participants. Completed in 1 December 2021.

Timeline

1 June 2020

Primary endpoint
1 June 2021

1 December 2021

Quick facts

Lead sponsor	Dr Medhat Khafagy
Status	Completed
Study type	OBSERVATIONAL
Enrollment	172
Start date	1 June 2020
Primary completion	1 June 2021
Estimated completion	1 December 2021
Sites	1 location across Egypt

Drugs / interventions tested

Complete blood picture, bone marrow aspiration cytology

Conditions studied

Lymphopenia — all drugs for Lymphopenia →

Sponsor

Dr Medhat Khafagy

Who can join

Eligibility, any sex, with Lymphopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study of the cause of lymphopenia in Covid19 viral infection will be done in 3 cohorts. First cohort will be patients asymptomatic or with mild symptoms. Second cohort will be patients with severe illness and admitted to ICU. Third cohort will be patients critically ill and on artificial ventilation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Lymphopenia

Currently open trials in the same condition.

NCT06181656 — Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemor · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04404608 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dr Medhat Khafagy
Last refreshed: 20 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04404608.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing